New York, September 25 (IANS) A study with Vitamin D and Omega-3 (fish oil) shows promise for the prevention of death from cancer and heart attacks, a new study shows.
The results are mixed but show
"The model of findings implies a complex balance of benefits and risks for each intervention and indicates the need for additional research to determine which individuals may be most likely to derive net benefit from the
Nearly 26,000 men and women in the United States have participated in the nationwide VITAL clinical trial.
After more than five years of study and treatment, the results show promising results.
For example, while Omega-3 fatty acids (fish oil) showed only a small but not significant reduction in the primary cardiovascular endpoint of major CVD events, they were associated with a significant reduction in heart attacks
The greatest benefit of treatment was observed in people with dietary intake of fish under the cohort averaging 1
The health benefits of heart are now confirmed by recent meta-analyzes of randomized omega-3 trials.
Similarly, vitamin D supplementation did not reduce significant CVD or overall cancer incidence but was associated with a statistically significant reduction in overall cancer mortality among those in the study for at least two years.
The effect of vitamin D on reducing cancer death is also confirmed by updated meta-analyzes of vitamin D trials to date.
The study is scheduled to be presented during the North American Menopause Society Annual Meeting (NAMS) in Chicago, September 25-28.